News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
78 Results
Type
Article (19)
Press Release (59)
Section
Business (45)
Deals (1)
Drug Development (9)
Job Trends (1)
News (50)
Policy (2)
Tag
Alliances (5)
Best Places to Work (1)
Clinical research (9)
Data (1)
Diabetes (1)
Diagnostics (1)
Earnings (5)
Events (5)
GLP-1 (3)
Healthcare (2)
Layoffs (1)
Medical device (1)
Medtech (1)
Mergers & acquisitions (1)
Metabolic disorders (3)
NextGen: Class of 2026 (2)
Non-profit (1)
Obesity (3)
People (27)
Phase 1 (2)
Phase 2 (7)
Pipeline (1)
Preclinical (1)
Real estate (2)
Regulatory (2)
Research institute (1)
Sponsored (1)
Startups (2)
Weight loss (2)
Date
Last 365 days (4)
2026 (1)
2025 (3)
2024 (3)
2023 (13)
2022 (28)
2021 (7)
2020 (4)
2019 (8)
2018 (5)
2017 (3)
2016 (2)
2015 (1)
Location
Asia (25)
Europe (29)
New York (3)
United States (3)
78 Results for "kallyope".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kallyope To Present at the 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
·
1 min read
Press Releases
Kallyope Announces 2026 Strategic Priorities for Migraine and Metabolism Portfolio Based on Novel Neural Circuits Platform
January 7, 2026
·
5 min read
Press Releases
Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment of Migraine
December 9, 2025
·
3 min read
Weight loss
Kallyope Discreetly Drops Disappointing Data for Oral Obesity Candidate
While Kallyope’s drugs are mechanistically unique, the biotech is competing in a crowded space, with other therapies that appear to elicit superior weight-loss.
February 27, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Kallyope Enters Phase 2 With First-in-class Oral Approach for the Treatment of Both Obesity and Type 2 Diabetes
Kallyope, Inc. today announced the initiation of their Phase 2 trial evaluating K-757 and K-833.
September 27, 2023
·
4 min read
Business
Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors
Kallyope, Inc. today announced the appointment of Franz Humer, Ph.D., a distinguished global industry leader in the life sciences, finance, and investment, as the new chair of its board of directors.
June 6, 2023
·
3 min read
Pharm Country
Kallyope Receives $8.2 Million Grant to Identify Novel Interventions for Children and Undernourished Pregnant Women and Mothers Experiencing Environmental Enteric Dysfunction
Kallyope , Inc. today announced that it has received $8.2 million from the Bill & Melinda Gates Foundation.
May 10, 2023
·
2 min read
Business
Kallyope and Brightseed Enter Collaboration to Identify and Validate Novel Plant-Based Bioactives
Kallyope and Brightseed have entered a strategic research collaboration to screen plant compounds to identify and validate active agents.
July 21, 2022
·
5 min read
Business
Investors Go with Their Gut, Dropping $236M into Kallyope
Kallyope focuses on the gut-brain axis, a bi-directional communication between the gastrointestinal tract and the brain.
February 15, 2022
·
2 min read
·
Mark Terry
Business
Renowned Biopharma Leaders Join Newly Established Kallyope Clinical Development Advisory Board
Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the formation of its inaugural Clinical Development Advisory Board.
August 5, 2022
·
4 min read
1 of 8
Next
